Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
88 Cards in this Set
- Front
- Back
|
MAGNESIUM SULFATE DOSE - OB
|
1-4 grams - SEIZURES
1-2 GRAMS - ASTHMA |
|
|
CALCIUM CHLORIDE DOSE - OB
|
0.5 -1 grams
|
|
|
BENADRYL DOSE - OB
|
25-50 MG
|
|
|
ZOFRAN DOSE - OB
|
4 MG
|
|
|
PHENERGAN DOSE - OB
|
12.5 - 25 MG
|
|
|
VALIUM DOSE - OB
|
5-10 MG
|
|
|
TERBUTALINE DOSE - OB
|
0.25 MG (SUB-Q)
|
|
|
PITOCIN DOSE - OB
|
10 UNITS
|
|
|
ATIVAN DOSE - PEDIATRIC
|
0.05 - 0.2 MG / KG
(MAY BE REPEATED ONCE IN 5-20 MINUTES WITH MAX DOSE OF ______ MG/KG) |
|
|
VALIUM DOSE - PEDIATRIC
|
0.2 - 0.5 MG / KG
MAY BE REPEATED IN 5-20 MINUTES MAX DOSE OF ___________MG |
|
|
SUCCS DOSE - PEDIATRIC RSI
|
PEDI - 1 - 1.5 MG / KG (REPEAT X 1 PRN)
INFANT- 2MG/KG |
|
|
ETOMIDATE DOSE - PEDIATRIC RSI
|
0.3 MG / KG
0.2-0.4 MG/KG OVER 30 SECONDS OLDER THAN 10Y/O 1 TIME DOSE MAX 20 MG |
|
|
LIDOCAINE DOSE - PEDIATRIC
ET TUBE AND RSI DOSES TOO |
1 MG / KG
MAX DOSE OF 100 MG ET TUBE DOSE: 2-3 MG/KG RSI: 1-2 MG/KG |
|
|
BENADRYL DOSE - PEDIATRIC
|
1 - 2 MG / KG
|
|
|
TYLENOL DOSE - PEDIATRIC
|
15 MG / KG (PO)
NOT RECOMMENDED FOR NEONATE |
|
|
ADENOSINE DOSE - PEDIATRIC
|
0.1 MG / KG
DO NOT EXCEED 6MG AND FOLLOW UP WITH 5-10ML FLUSH SECOND DOSE: 0.2 MG/KG RAPID IVP (NOT TO EXCEED 12 MG) |
|
|
AMIODARONE DOSE - PEDIATRIC
|
5 MG / KG
REPEAT DOSE: 15MG/KG MAX SINGLE DOSE OF 300 MG |
|
|
ALBUTEROL DOSE - PEDIATRIC
|
2.5 MG IN
|
|
|
NARCAN DOSE - PEDIATRIC
|
0.1 MG / KG
MAX DOSE OF 2 MG |
|
|
RACEMIC EPINEPHRINE DOSE - PEDIATRIC
|
0.5 MG IN 3 ML SALINE NEBULIZED - - BRONCHIOLITIS
|
|
|
DEXTROSE DOSE - PEDIATRIC/NEONATE/ >2Y/O
|
NEONATE <30 DAYS D10- 2 ML / KG
PEDI 31 DAYS TO 2 YEARS- D25- 2-4 ML/KG 2 YEARS AND OLDER- 1-2 ML/KG D50 |
|
|
ELECTRICAL THERAPY IN PEDIATRICS: CARDIOVERSION
|
0.5-1 joules/ KG initial shock.
2 JOULES / KG. remaining shocks |
|
|
ELECTRICAL THERAPY IN PEDIATRICS: DEFIBRILLATION
|
2 JOULES/KG INITIAL SHOCK
4 JOULES/KG - ALL FOLLOWING SHOCKS |
|
|
FLUID THERAPY DETAILS
|
10 ML / KG FOR NEONATES
20 ML / KG FOR EVERYBODY ELSE |
|
|
MAG SULFATE CLASS
|
ELECTROLYTE, ANTI-INFLAMMATORY
|
|
|
MAG SULFATE: MOA
|
Reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Manages seizures in toxemia of pregnancy. Induces uterine relaxation. Can cause bronchodilation after beta-agonists and anti-cholinergics have been administered.
|
|
|
MAG SULFATE: INDICATIONS
|
Seizures of eclampsia (toxemia of pregnancy), tor- sades de pointes, hypomagnesaemia, ventricular fibrillation/ pulseless ventricular tachycardia that is refractory to amioda- rone, life-threatening dysrhythmias due to digitalis toxicity.
|
|
|
MAG SULFATE: CONTRAINDICATIONS
|
Heart block, myocardial damage.
|
|
|
MAG SULFATE: ADULT DOSE/ADMINISTRATION
|
Adult: Seizure activity associated with pregnancy: 1–4 g of a 10% solution IV/IO over 3 minutes; maximum dose of 30–40 g/day. Cardiac arrest due to hypomag- nesaemia or torsades de pointes: 1–2 g of a 10% solution IV/IO over 5–20 minutes. Torsades de pointes with a pulse: Loading dose of 1–2 g in 50–100 mL of D5W over 5–60 minutes IV. Fol- low with 0.5–1 g/h IV (titrate dose to control torsades).
|
|
|
MAG SULFATE: PEDIMAG SULFATE:
|
Pediatric: Pulseless ventricular tachycardias with torsades de pointes: 25–50 mg/kg IV/IO bolus of a 10% solution to a maximum dose of 2 grams. Torsades de pointes with pulses/hypomagnesaemia: 25–50 mg/kg IV/IO of a 10% solution over 10–20 minutes to maximum dose of 2 grams. Status asthmaticus: 25–50 mg/kg IV/IO of a 10% solution over 15–30 minutes to a maximum dose of 2 grams.
|
|
|
CALCIUM CHLORIDE: CLASS
|
ELECTROLYTE (ANION)
|
|
|
CALCIUM CHLORIDE: MOA
|
Increases cardiac contractile state (positive inotropic effect). May enhance ventricular automaticity.
|
|
|
CALCIUM CHLORIDE: INDICATIONS
|
Hypocalcemia, hyperkalemia, HYPERMAGNESEMIA, beta blocker and calcium channel blocker toxicity.
|
|
|
CALCIUM CHLORIDE: CONTRAINDICATIONS
|
Hypercalcemia, ventricular fibrillation, dig- italis toxicity.
|
|
|
CALCIUM CHLORIDE: ADULT DOSE/ADMIN
|
Adult: Calcium channel blocker overdose and hyperkalemia: 500 mg to 1,000 mg (5–10 mL of 10% solution) IV push. May repeat as needed.
|
|
|
CALCIUM CHLORIDE: PEDI DOSE/ADMIN
|
Pediatric: Calcium channel blocker overdose and hyperkalemia: 20 mg/ kg (0.2 mL/kg) slow IV/IO push. Maximum 1-g dose; may repeat in 10 minutes.
|
|
|
BENADRYL: CLASS
|
ANTIHISTAMINE, ANTICHOLINERGIC
|
|
|
BENADRYL: MOA
|
Blocks cellular histamine receptors; decreases vasodilation; decreases motion sickness. Reverses extrapyramidal reactions.
|
|
|
BENADRYL: INDICATIONS
|
Symptomatic relief of allergies, allergic reactions, and anaphylaxis. Blood administration reactions; used for motion sickness and hay fever, relief of acute dystonic reactions caused by phenothiazines; may be useful in phenothiazine over- doses.
|
|
|
WHAT IS THE TREATMENT FOR HYPEREMESIS GRAVIDARUM?
|
10-50 MG OF BENADRYL IVP OR DEEP IM
|
|
|
BENADRYL: CONTRAINDICATIONS
|
Asthma, glaucoma, pregnancy, hyperten- sion, narrow-angle glaucoma, infants, patients taking MAOIs.
|
|
|
BENADRYL: ADULT DOSE/ADMIN
|
Adult: 25–50 mg IM, IV, PO.
|
|
|
BENADRYL: PEDI DOSE/ADMIN
|
Pedi- atric: 1–2 mg/kg IV, IO slowly, or IM. If PO: 5 mg/kg/24h.
|
|
|
ZOFRAN: CLASS
|
Serotonin receptor antagonist; antiemetic
|
|
|
ZOFRAN: MOA
|
Blocks action of serotonin, which is a
natural substance that causes nausea and vomiting |
|
|
ZOFRAN: INDICATIONS
|
For the prevention and control of nausea or vomit- ing. Used in hospital for patients undergoing chemotherapy or surgical procedures.
|
|
|
ZOFRAN: CONTRAINDICATIONS
|
Known allergy to ondansetron or other 5-HT3 receptor antagonists.
|
|
|
ZOFRAN: ADULT DOSE/ADMIN
|
Adult: 4 mg IV/IM may repeat in
10 minutes. |
|
|
ZOFRAN: PEDI DOSE/ADMIN
|
Pediatric: 0.1 mg/kg IV/IM.
|
|
|
PHENERGAN CLASS
|
Phenothiazine, antiemetic, antihistamine.
|
|
|
PHENERGAN: MOA
|
H-1 receptor antagonist; blocks action of histamine; possesses sedative, anti-motion, antiemetic, and anti- cholinergic activity; potentiates the effects of narcotics to induce analgesia.
|
|
|
PHENERGAN- INDICATIONS
|
Nausea/vomiting, motion sickness, sedation for patients in labor, potentiates the analgesic effects of narcotics.
|
|
|
PHENERGAN- CONTRAINDICATIONS
|
Coma, central nervous system depression from alcohol, barbiturates, or narcotics, Reye syndrome, lower respiratory symptoms (eg, asthma).
|
|
|
PHENERGAN- ADULT
|
Adult:12.5–25mgIV,deepIM,PO,
PR. |
|
|
PHENERGAN-PEDI
|
Pediatric (older than 2 years): 0.25–0.5 mg/kg dose deep IM.
|
|
|
VALIUM-CLASS
|
Benzodiazepine, long-acting; sedative-hypnotic; anticon- vulsant; schedule IV drug.
|
|
|
VALIUM- MOA
|
Potentiates effects of inhibitory neu- rotransmitters. Raises the seizure threshold. Induces amnesia and sedation.
|
|
|
VALIUM-INDICATIONS
|
Acute anxiety states and agitation, acute alcohol withdrawal, muscle relaxant, seizure activity, sedation for medi- cal procedures (eg, intubation, ventilated patients, cardiover- sion), may be helpful in acute symptomatic cocaine overdose.
|
|
|
VALIUM-CONTRAINDICATIONS
|
Hypersensitivity, narrow-angle glaucoma, myasthenia gravis, respiratory insufficiency, coma, head injury.
|
|
|
VALIUM- ADULT DOSE
|
Adult: Seizure activity: 5–10 mg IV q 10–15 minutes PRN (5 mg over 5 minutes) (maximum dose: 30 mg). Premedication for cardioversion: 5–15 mg IV over 5–10 minutes prior to cardioversion.
|
|
|
VALIUM-PEDI DOSE
|
Pediatric: Seizure activ- ity: 0.2 mg/kg to 0.5 mg/kg slow IV q 2–5 minutes up to 5 mg (maximum dose 10 mg/kg). Rectal diazepam: 0.5 mg/kg via 2" rectal catheter and flush with 2–3 mL air after administration.
|
|
|
TERBUTALINE- CLASS
|
Beta-2 adrenergic agonist, bronchodilator.
|
|
|
TERBUTALINE-INDICATIONS
|
Bronchial asthma, reversible bronchospasm associ- ated with exercise, chronic bronchitis, emphysema.
|
|
|
TERBUTALINE-MOA
|
Selective beta-2 adrenergic receptor activity resulting in relaxation of smooth muscle of the bronchial tree and peripheral vasculature with minimal cardiac effects. -
|
|
|
TERBUTALINE-CONTRAINDICATIONS
|
Hypersensitivity, tachydysrhythmias.
|
|
|
TERBUTALINE-ADULT DOSE
|
Adult: 0.25 mg SC may repeat in 15–30 minutes to maximum dose of 0.5 mg in a 4-hour period.
|
|
|
TERBUTALINE-PEDI DOSE
|
Pediatric: Not recommended for children younger than 12 years of age. 0.25 mg SC may repeat in 15–30 minutes to maximum dose of 0.5 mg in a 4-hour period.
|
|
|
TERBUTALINE (OTHER NAME?)
|
BRETHINE
|
|
|
TERBUTALINE- ADVERSE REACTIONS
|
CNS stimulation, headache,
seizure, restlessness, apprehension, wheezing, coughing, bronchospasm, bradycardia, tachycardia, ST wave changes, PVCs, PACs, chest pain. |
|
|
WHAT DOES TERBUTALINE DO FOR PRETERM LABOR?
|
SUPPRESSES PRE-TERM LABOR WITH .25 MG SUBQ AND REPEAT AFTER 30 MINUTES.
|
|
|
TERBUTALINE- DRUG INTERACTIONS
|
Cardiovascular effects exacerbated by other sympathomimetics. MAOIs may potentiate dysrhythmias. Beta blockers may antagonize terbutaline.
|
|
|
PITOCIN: CLASS
|
Pituitary hormone.
|
|
|
PITOCIN- MOA
|
Increases uterine contractions. ALSO USED FOR POSTPARTUM HEMORRHAGE AFTER I
|
|
|
WHAT ELSE IS PITOCIN USED FOR, AND HOW IS IT ADMINISTERED?
|
ALSO USED FOR POSTPARTUM HEMORRHAGE AFTER INFANT AND PLACENTAL DELIVERY - 3-10 UNITS IM OR IVP. MIX WITH 10-20 UNITS IN 500-1000 ML AND SLOWLY TITRATE TO EFFECT
|
|
|
PITOCIN- INDICATIONS
|
Postpartum hemorrhage after infant and placental delivery.
|
|
|
PITOCIN-CONTRAINDICATIONS
|
Presence of second fetus, unfavorable fetal position.
|
|
|
PITOCIN- ADVERSE REACTIONS
|
Coma, seizures, anxiety, sub- arachnoid hemorrhage, hypotension, tachycardia, dysrhythmias, chest pain, nausea, vomiting, painful uterine contractions, uter- ine rupture.
|
|
|
PITOCIN- DRUG INTERACTIONS
|
Other vasopressors may potentiate hypotension.
|
|
|
PITOCIN- ADULT DOSE
|
Adult: IM administration: 10 units IM following delivery of the placenta. IV administration: Mix 10–40 units in 1,000 mL of nonhydrating diluent: Infused at 20–40 milliunits/min. Titrated to severity of bleeding and uter- ine response.
|
|
|
PITOCIN-PEDI DOSE
|
Pediatric: Not applicable.
|
|
|
PEDIATRIC EPI: ALLERGIC REACTION
|
0.01 MG/KG IM 1: 1,000 (MAX 0.3 MG)
|
|
|
PEDIATRIC EPI: CARDIAC ARREST
|
0.01 MG/KG 1:10,000 IO/IVP
|
|
|
PEDIATRIC EPI: ET DOSES
|
0.1 MG/KG 1:1,000 MIXED IN 3-5 ML SALINE
|
|
|
PEDIATRIC EPI: BRADYCARDIA
|
0.01 MG/KG 1:10,000 IO/IVP
|
|
|
PEDIATRIC ATROPINE: UNSTABLE BRADYCARDIA
|
.02 MG/KG IO/IVP (REPEAT ONCE)
|
|
|
CHILD ATROPINE: UNSTABLE BRADYCARDIA
|
0.5 MG REPEAT ONCE (MAX 1 MG)
|
|
|
ADOLESCENT ATROPINE: UNSTABLE BRADYCARDIA
|
1MG (MAX OF 3 MG)
|
|
|
PEDI ATROPINE: RSI
|
0.01-0.02 MG/KG IO/IVP (MAX 0.5MG)
|
